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Background: To complement ongoing schistosomiasis control within national control programmes (NCPs) that
administer praziquantel to school-age children, assessing the risk and extent of schistosomiasis in pre-school-age
children (PSAC) is important.
Methods: In June 2012, schistosomiasis in Chikhwawa district, Malawi was assessed across 12 villages examining
pre-school-age children (PSAC) and their mothers by serological and parasitological diagnosis, as supplemented
with urine-antigen and questionnaire-interview methods. Urinary tract morbidity was inferred by haematuria and
albuminuria assays.
Results: In total, 49.5% (CI95 42.6-56.4) of 208 PSAC and 94.5% (CI95 90.9-98.1) of 165 mothers were seropositive for
schistosomiasis, in 2 villages seroprevalence exceeded 75% in PSAC. Egg-patent urogenital and intestinal
schistosomiasis was observed; 17.7% (CI95 12.4-23.2) of PSAC and 45.1% (CI95 37.4-52.8) of mothers having active
schistosomiasis by parasitological and urine-antigen testing combined. PSAC often had extensive daily water
contact and many (~25%) had haematuria and albuminuria. As eggs with an atypical morphology of Schistosoma
haematobium were observed, a general selection of schistosome eggs was characterized by DNA barcoding, finding
Group I S. haematobium and Group IV and V S. mansoni. Malacological surveys encountered several populations of
Bulinus globosus but failed to find Biomphalaria.
Conclusions: Both PSAC and their mothers appear to be at significant risk of schistosomiasis and should be
considered for treatment within the NCP of Malawi.
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ZoonosisBackground
Two major forms of schistosomiasis exist in sub-Saharan
Africa (SSA), urogenital and intestinal, each caused by in-
fection with different schistosome species, Schistosoma
haematobium and S. mansoni, respectively [1]. In order to
complete their lifecycles, schistosomes require aquatic
intermediate snail hosts, thus the distribution of susceptible* Correspondence: r.stothard@liv.ac.uk
1Department of Parasitology, Liverpool School of Tropical Medicine,
Pembroke Place, Liverpool L3 5QA, UK
Full list of author information is available at the end of the article
© 2014 Poole et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.populations of Bulinus and Biomphalaria broadly outlines
the endemic areas where urogenital and intestinal schisto-
somiasis occur [2]. Surveying local freshwater habitats for
such snails is particularly useful for assessing transmission
risk [3,4] and often allowing differentiation between au-
tochthonous or imported infections as recently shown for
intestinal schistosomiasis on the Sesse Islands, Uganda or
urogenital schistosomiasis on Mafia Island, Tanzania [5,6].
Whilst co-infection of both types of schistosomiasis is
known, its extent remains poorly quantified but it is
likely that several tens of millions live with both formstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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genetic introgression between species previously [8]. In
addition, there is now growing evidence for zoonotic
transmission of urogenital schistosomiasis, so surveil-
lance systems should become increasing alert to this
possibility [9]. Thus where sanitation and water hygiene
is poor, up to 800 million people are at risk of schisto-
somiasis and this is often coupled with low levels of dis-
ease awareness among afflicted communities [10,11].
Preventive chemotherapy with praziquantel (PZQ) is the
main control strategy [12]. With international support
[7], several national control programmes (NCPs), includ-
ing Malawi, are active in conducting mass drug adminis-
tration (MDA) of PZQ. Indeed access to PZQ has
expanded vastly in recent years [1,7,12] and in line with
the WHO Strategic Plan for Control of Schistosomiasis,
in the forthcoming 2012-2020 period, further scale-up of
MDA is predicted in SSA with up to 250 million tablets
earmarked each year for treatment of school-aged chil-
dren (SAC) alone [11].
In highly endemic areas, however, members of the
community other than SAC can be infected. Such groups
are often overlooked in terms of their treatment needs
[13-15]. For example, recent attention has focused upon
documenting prevalence of infection in pre-school-age
children (PSAC) and in so doing has defined a clear ‘PZQ
treatment gap’, i.e., PSAC in need of treatment are gener-
ally excluded from MDA programmes [14,16,17]. The rea-
sons behind this gap are complex but include the absence
of a suitable PZQ pediatric formulation. The WHO has
now recognized that where a need is shown, infected
PSAC should be provided with crushed or broken PZQ
tablets [11,15,18,19], as a pragmatic stop-gap [13,20-22],
until an appropriate pediatric PZQ formulation becomes
available.
To better estimate disease, it remains important to
collect up-to-date epidemiological information to inform
treatment strategies generally [23,24] and specifically
that needed for PSAC in the context of present and fu-
ture control [13]. Diagnosis of schistosomiasis in young
children is problematic as there is no ‘gold-standard’
[14,23]. The detection of infections in PSAC is some-
what different to older children as the adult worm pairs
are themselves maturing into full fecundity, so egg-
detection methods perform poorly having a significant
time-delay lagging behind the patency of either antibody
or antigen methods [25]. Serological analysis by detec-
tion of host antibodies to schistosome soluble egg anti-
gen (SEA) is recognized as the most sensitive method of
detection but cannot differentiate between the different
forms of schistosomiasis or identify co-infection [25,26],
while egg-detection methods, which are generally ac-
knowledged to lack sensitivity, have high specificity for
each type of schistosomiasis [11]. In Uganda, for example,using a combined diagnostic approach of host serology (i.e.,
SEA-ELISA for IgM/G antibodies) and urine-antigen rapid
diagnostic tests (i.e., urine immuno-chromatographic dip-
sticks for circulating cathodic antigen (CCA)) demonstrated
that over 50% of PSAC had intestinal schistosomiasis
[25,27]. Many of these children also had overt morbidity,
including organomegaly, anemia and stools positive in fae-
cal occult blood [28,29]. In Cote d’Ivoire, Niger, Nigeria
and Mali, urogenital schistosomiasis can be common in
PSAC [15,30,31]. Putative morbidity can be assessed by
ultrasonography and by POC assays for haematuria and
albuminuria, used alongside detection of intestinal schis-
tosomiasis with urine-CCA dipsticks [7,32-34].
In Malawi the schistosomiasis NCP focuses upon
treatment of SAC and the epidemiology of schistosomia-
sis, albeit urogenital or intestinal forms, in PSAC is pres-
ently unclear. Here we report on a pilot investigation of
schistosomiasis in PSAC and their mothers in an area
around Chikhwawa town, located in the Lower Shire
River valley. The epidemiological survey was structured
to address, as best possible, infections within PSAC
using a combination of diagnostic methods with sero-
logical and parasitological methods supplemented with
urine-antigen and questionnaire-interview methods. To
estimate levels of urinary tract disease, assays for detection
of haematuria and albuminuria were applied. To further
investigate aspects of the local epidemiology of schisto-
somiasis, molecular characterization of encountered schis-
tosomes was undertaken alongside malacological surveys
to estimate environmental risk of transmission.
Methods
Study area and participants
Chikhwawa district is located within the southern low-
land region of Malawi (16° 1′ S; 34° 47′ E), an area char-
acterized by a tropical climate with mean annual
temperature of 26°C, a single wet season from November
to April, and annual rainfall of approximately 770 mm
(Malawi Meteorological Office, Chileka, Blantyre). The
Lower Shire River empties directly from Lake Malawi
and flows in a Southern direction. Flooding and the
development of water bodies up to several kilometers
away from the river are common following the rainy sea-
son. Major local agricultural projects also have extensive
irrigation systems, e.g. at the Nchalo sugar cane estate.
There are large roving herds of cattle, however, the
extent of bovine schistosomiasis, or its zoonotic poten-
tial, is unknown.
A continuous Malaria Indicator Survey assessing the
year round intervention coverage and disease burden
was ongoing in children aged 6-59 months and adults
from over 50 villages within Chikhwawa [35,36]. In July
2012 a survey for schistosomiasis in PSAC was con-
ducted alongside this survey in 12 villages that represent
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point of survey, GPS co-ordinates in decimal degrees
were taken using a handheld e-trex unit (Garmin,
Southampton, UK) to enable later cartography. In line
with rapid survey methods for schistosomiasis [11], a
target of 15 consenting mothers each with a child aged
between 6 months to 5 years from within the sampled
village were invited to participate in a semi-random
sample; if a mother was selected and had more than one
child within this age range, then her other children were
also included.
Specimen collection, diagnostic procedures and PZQ
treatment
As parasitological methods are known to be insensitive,
host serology was considered to be most informative in
the context of the PSAC as a single serum sample can
be obtained directly with minimal discomfort and there
are now commercially available ELISA kits that can be
used in resource poor laboratories [25]. Between 4 to 5
drops of fingerprick blood were collected from each par-
ticipant, allowed to clot in a 1.5 ml eppendorf tube and
stored a cool box until later centrifugation at 6,000 rpm
for 10 minutes in a portable micro-centrifuge (Galaxy
Ministar, VWR, Pennsylvania, USA). A total of 2.5 μl
sera was used in a commercially available SEA-ELISAFigure 1 A sketch map of snail collecting sites around Chikhwawa sh
by SEA-ELISA by pie-charts denoting prevalence in PSAC (black pie sekit, Schistosoma Antibody Detection Test (SCIMEDX,
New Jersey, USA). To ensure consistency, positive and
negative controls were loaded onto each ELISA plate at
the beginning and end of loading of sera samples [25].
ELISA plates were processed and incubated according to
manufacturer’s protocols. Upon completion, reaction
wells were examined visually against a white card back-
ground, by 2 people independently. Reactions were
graded as strong positive (+++), medium positive (++),
light positive (+), trace (tr) and negative (-) using a
standard photograph of wells demonstrating this range
from dark yellow to colourless.
Owing to logistic constraints in terms of local tech-
nical microscopy support and an anticipated low endem-
icity of S. mansoni and soil-transmitted helminthiasis
(STH), parasitological examination of faecal material
was performed in the first 6 villages only. In these 6 vil-
lages, 100 ml plastic containers were distributed to adult
and child participants the evening before the day of sur-
vey for collection of a morning stool specimen. Urine
containers were distributed to participants in all 12 vil-
lages for collection of a mid-morning sample from each
mother and her child/children on the day of survey. A
single thick Kato-Katz (41.7 mg) smear was prepared
from stool samples on the day of collection to detect in-
testinal schistosomiasis and STH [25]. This was examinedowing the 12 villages surveyed for schistosomiasis as indicated
gment infected) and in mothers (outer line segment infected).
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readers, for the presence of helminth eggs. Eggs were
counted, tabulated, expressed as mean eggs per gram
(epg) of faeces and then classified according to WHO
egg intensity guidelines, e.g. for intestinal schistosomiasis
of light (< 100 epg), medium (≥100 & < 400) and heavy
(≥ 400 epg) categories, for each species of infecting hel-
minth [11]. To increase the sensitivity of urine filtration
to detect urogenital schistosomiasis, 20 ml of urine was
filtered by plastic syringe through a 13 mm diameter
cut circular nylon filter of 35 μm pore-size. Filters were
then stained with a drop of Lugol’s iodine and viewed
under microscopy (x100) counting eggs of S. haemato-
bium to be later expressed as light (< 50 eggs/10 ml) or
heavy (≥ 50 eggs/10 ml) infection intensities according
to WHO guidelines [11].
All urine samples were tested for the presence of
schistosome CCA on site using a lateral flow immuno-
chromatographic urine dipstick RDT (Rapid Medical
Diagnostics, Pretoria, South Africa). The urine CCA-
dipstick is currently advocated as an alternative mapping
tool to Kato-Katz for the detection of intestinal schisto-
somiasis and is not recommended for detection of uro-
genital schistosomiasis owing to very low sensitivity
[25,26,37,38]. According to the visual staining intensity
of the test band, results were classed as negative (-),
trace (tr), positive (+), medium positive (++) or strong
positive (+++). Visual trace results were considered
negative in the analysis of results and any positive result
was interpreted as indicative of an active infection with
S. mansoni [37].
Indirect measures of urinary tract morbidity and levels
of anaemia
Documentation of putative pathology associated with uro-
genital schistosomiasis was assessed by proxy methods of
urine analysis including: visual inspection, reagent strip
analyses and POC urine-albumin assays. Anaemia was
quantified by point-of-contact (POC) haemoglobin mea-
surement. Visual inspection - all urine samples were visu-
ally inspected for colour and clarity using a colour chart
and turbidity scale (lined barcode pattern) placed under-
neath the urine container. Reagent strip analyses - the
presence of blood, protein, nitrates and leucocytes was es-
timated. POC urine-albumin - urine albumin was quanti-
fied using the Hemocue® albumin system (Hemocue,
Sweden). Turbidity was removed from the urine sample
by centrifuging 0.5 ml of each urine sample in a 0.5 ml
Eppendorf tube for 5 minutes at 6000 rpm in a portable
micro-centrifuge (Galaxy Ministar, VWR, Pennsylvania,
USA) before a visual turbidity absorption reading was
taken using the Hemocue® cuvette, expressing urine-
albumin concentration from 5-150 mg/l. Samples above
this range were diluted by 1:3 serial dilutions in normalsaline as recommended by the manufacturer until a read-
ing within range was obtained. Anaemia – a fingerprick
blood sample was used to measure haemoglobin concen-
trations of mothers and children (Hemocue® Hb201+ sys-
tem, Hemocue, Sweden). As Chikhwawa is below 150 m
above sea level, altitude correction was not required.
Case history questionnaire and recalled water contact
patterns
Each mother was interviewed using a standardized ques-
tionnaire in the local language (Chichewa). Data were
collected on socio-demographic factors (i.e., age, sex,
educational level), knowledge and awareness of the dis-
ease, its basic symptoms, and water-use and water con-
tact patterns. A copy of the questionnaire is available
upon request from the corresponding author.
Molecular characterization of schistosomes
In order to retrieve schistosome eggs for DNA barcod-
ing, pooled stool or urine samples were obtained from
infected children at Kapsasule, Mpangeni and Mwaliga
(see Figure 1) and processed as previously decribed
[39-41]. Eggs or hatched miracidia were harvested by
pippette in 3 μl of water then placed onto FTA indicator
cards. From the FTA punch material, a 956 bp region of
the mitrochondrial cyctochrome oxidase subunit 1 (cox1)
gene, or DNA barcode, was amplified for S. haematobium
in separate 25 μl PCR reactions using illustraTM puReTaq
Ready-To-Go PCR Beads (GE Healthcare, UK) and 10
pmol of each primer (Forward primer: COX1_Schisto_5′;
Reverse primer; COX1_Schist_3) [40]. For S. mansoni, a
540 bp fragment was amplified or 3 μl of genomic DNA
using the ASMIT1 and Cox1_Schist_3′ primers and
illustra™ puReTaq Ready-To-Go PCR Beads (GE Health-
care) [39]. Amplification products were later sequenced in
both forward and reverse directions for assembly as edited
with Sequencher ver. 4.6 (http://www.genecodes.com). Se-
quences were then compared against those in EMBL/Gen-
bank using the Basic Local Alignment Search Tool
(BLAST) to ascertain which of the known groups of S.
haematobium (Group I or II) [40] and S. mansoni (Group
I, II, III, IV or V) would be assigned [41].
Malacological surveys for freshwater snails
Prior to the parasitological surveys, each village was vis-
ited to inspect local freshwater habitats for freshwater
snails. To find sites, a combination of GoogleEarth satel-
lite imagery was used in conjunction with local know-
ledge of villagers and direct sighting of marshy areas/
standing water bodies. Owing to local access opportun-
ities, a total of 16 freshwater sites were inspected for
snails using hand held metal scoops and direct picking
with forceps. Temperature, water conductivity and pH
were recorded at each site using a handheld meter
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contact of PSAC was also made, and recorded by pho-
tography, at the time of survey in or around the fresh-
water habitat. Sampling at each site was semi-quantified,
with two collectors surveying each for approximately 20
minutes at each site. All collected snails were exposed to
sunlight for several hours to check for infection with
Schistosoma spp. or other parasite cercariae. Snail spe-
cies were identified on the basis of shell morphology and
for species within the Bulinus africanus group, by ana-
tomical dissection and inspection of the genitalia [2].
Ethical considerations and treatment
Ethical approval was granted from the College of Medi-
cine Research Ethics Committee (COMREC, Blantyre,
Malawi) and from the LSTM Research Ethics Committee
(Liverpool, UK). Local support was received from the
District Health Officer and village chiefs. After commu-
nity village sensitization, written informed consent was
obtained for women and children from each mother ei-
ther as a signature or thumbprint.
Any mother or PSAC that was found infected by either
urine-CCA dipsticks or upon evidence of haematuria by
reagent strips was treated on site with PZQ (40 mg/kg).
To facilitate accurate dosing, patient’s weight was mea-
sured for all participants using a digital weighing scale
[19-21]. Younger children were provided with crushed
tablets as mixed with orange syrup along with a local food
item (biscuit) and potable water. After treatment, all chil-
dren were monitored informally for up to 2-3 hours to
monitor for immediate complications such as vomiting.
Upon completion of SEA-ELISA and parasitological test-
ing, a second visit to each village was undertaken to en-
sure that all positive participants received PZQ treatment.
Data management and statistical analyses
Data were recorded onto paper-format questionnaires
and results sheets using participants’ unique study num-
bers and double entered into Excel (Microsoft, USA).
Discrepancies were resolved upon inspection of paper
copy records. Univariate and multi-variate analyses were
performed in SPSS (v. 20 IBM SPSS statistics 2011) to
assess associations between infection status and putative
risk factors from case-history questionnaire data collec-
tion (i.e. recalled water contact).
Results
Prevalence of schistosomiasis
165 mothers (mean age 28 years range 18-47) and 208
children (mean age 36 months range 9-66, gender ratio
1.1 boys:girls) participated in the study. 94.5% of mothers
(CI95 90.9-98.1) and 49.5% of PSAC (CI95 42.6-56.4) were
seropositive for schistosomiasis by SEA-ELISA. The geo-
graphical distribution of seropositive PSAC and mothersacross the 12 villages is shown in relation to the main
water bodies and where Bulinus snails were encountered
(Figure 1). The seroprevalence varied widely from over
50% of PSAC in Kapasule, Mpangani, Mwalija, Chikambe
3 and Santana villages to less than 5% in Chinangwa 1 and
Namila, indicating a focal distribution. Both the propor-
tion of positive SEA-ELISAs and the titre increased with
increasing age of children ranging from 37.2% (CI95 22.1-
52.3) in PSAC aged 1 to 78.1% (CI95 62.9-93.2) in PSAC
aged 5 years (Figure 2). There was no significant difference
in prevalence between boys and girls. In total, 45.1% (CI95
37.4-52.8) of mothers and 17.7% (CI95 12.4-23.2) of chil-
dren were found to be infected by parasitological (urine-
filtration) and/or CCA-dipstick testing.
In the 6 villages where stool samples were examined,
egg patent S. mansoni infection was observed in 21.5%
(CI95 12.3-30.7) of mothers but only one 5 year-old boy.
In these 6 villages the urine CCA-dipstick was positive
in 33.3% (CI95 22.8-43.8) in mothers and 10.5% (CI95
4.3-16.8) in children. The overall prevalence based on
CCA dipsticks across all 12 villages was 24.9% for
mothers (CI9518.2-31.5) and 9.1% for children (CI95 5.1-
13.2). No other helminth ovum was seen in the stool.
Microscopy of filtered urine showed that 25.0% of
mothers (CI95 18.3-31.7) and 10.7% (CI95 6.4-15.1) of
children were excreting eggs of S. haematobium. Three
mothers had atypical eggs of a terminal spined schisto-
some that were approximately twice the typical 80-90
μm length of S. haematobium. The highest egg-patent
prevalence of urogenital schistosomiasis was found at
Kapasule with 60.0% (CI95 31.9-88.1) of mothers and
42.8% (CI95 19.7-65.9) in PSAC indicative of a local hot-
spot and consistent with SEA-ELISA findings.
Pooling of positive results from all three techniques
(stool & urine examination, CCA-dipsticks and SEA-
ELISA) demonstrated an overall prevalence of 53.9% (CI95
47.0-60.9) in PSAC (Figure 3). As children are seronega-
tive for schistosomiasis until they acquire their first infec-
tion, the SEA-ELISA can be considered the most sensitive
method for detection of initial active infection but cannot
differentiate between the two forms of schistosomiasis
and might time-lag slightly behind urine-antigen methods.
Urine-CCA dipsticks are considered to be excellent proxy
markers of intestinal schistosomiasis and are not con-
founded in this instance by urogenital schistosomiasis.
The prevalence of co-infection with both S. haematobium
and S. mansoni was estimated to be 8.5% in mothers (CI95
4.2-12.8) and 3.6% in children (CI95 1.0-6.2) using criteria
of a positive CCA-dipstick (S. mansoni) and urine-
filtration/microhaematuria (S. haematobium).
Indirect markers of morbidity
38 mothers and 17 children had turbid urine upon visual
inspection. This was significantly associated with egg
Figure 2 Observed prevalence of SEA-ELISA positive results in PSAC by age group and by strength of reaction.
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children (OR 8.1 CI95 4.2 – 15.3). Only 4 mothers and 2
children presented with macrohaematuria; all of these
were egg-patent for S. haematobium. Reagent strip test-
ing demonstrated microhaematuria in 45 women (40.0%
[CI95 32.5-47.5] and 57 children (24.4% [CI9518.3-30.4]
haematuria). The presence of microhaematuria was sig-
nificantly associated with egg patent S. haematobiumFigure 3 Prevalence of schistosomiasis as assessed by different diagn
[CI95 around the prevalence are indicated].infection in all participants (OR 15.5 CI95 7.8 – 30.9)
and clearly increased with child age, Figure 4A & B. Ele-
vated urine albumin levels (>40 mg/l) were seen in
26.7% of mothers and 17.3% of children, with no signifi-
cant difference between boys and girls. The mean levels
of urine-albumin related to results of diagnostic methods
for S. haematobium are shown in Table 1; significantly
higher levels of urine-albumin were associated withostic methodologies in PSAC and mothers across the 12 villages
Figure 4 A & B Frequency of egg-patent urogenital schistosomiasis increases with age of the child (A), microhaematuria is also associated
with increasing age (B).
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the relationship between urine-albumin and egg-patent
infection with S. haematobium is shown in Figure 5.
Upon fingerprick blood testing, clinical anemia was
present in 40.6% mothers (<120 g/L) and 71.9% of chil-
dren (<110 g/L). The mean hemoglobin for mothers was
122.5 g/L (CI95 120.1–125.0) and 101.1 g/L for children
(CI95 99.0-103.1). There was no statistically significant
difference between hemoglobin levels in children in rela-
tion to sex or infection with schistosomiasis (using any
diagnostic method).
Case history questionnaire and recalled water contact
patterns
The majority of mothers had received little or no formal
education; 44% of the mothers had never attendedTable 1 Mean urine albumin values and relationship with par
(microhaematuria) of infection with S. haematobium
Mothers
Mean urine albumin (mg/L)
All 11.9
S. haematobium egg-negative 7.4
S. haematobium egg-positive 43.3
SEA-ELISA negative 14.3
SEA-ELISA positive 11.7
No microhaematuria 6.3
With microhaematuria 27.2school, 53% had attended at primary level and just 3%
having attended secondary education. All mothers re-
ported that the central district hospital (Chikhwawa) was
where they took their children if they became unwell.
General awareness of schistosomiasis was very poor, 97%
of the women had little or no knowledge of the disease,
despite a quarter of them verbally reporting to have had
previous PZQ treatment.
All but one family had access to safe water via working
boreholes in every village. However, 18% and 54% of
mothers respectively would wash themselves or their
clothes in environmental water (rivers, lakes or canals).
Up to 20% of PSAC were reported to be bathed at least
once (60%) or twice (38%) in this potentially contami-
nated water each day. 41% of PSAC were spending more
than 30 minutes in or around the water margins eachasitological, immunological and proxy marker
Children
CI95 Mean urine albumin (mg/L) CI95
9.1 – 15.4 7.6 5.9 – 9.8
5.8 – 9.8 5.7 4.4 – 7.5
28.6 – 65.5 49.0 20.1 – 117.4
7.1 – 27.9 4.1 2.9 – 5.6
8.9 – 15.3 13.9 9.2 – 20.7
4.6 – 8.5 4.6 3.4 – 6.1
18.8 – 39.2 27.1 16.1 – 45.1
Figure 5 Raised urine albumin levels (> 40 mg/L) in relation to egg-patent infection with S. haematobium reveal underlying urinary
tract pathology in young children.
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between egg-patent schistosomiasis and the potential
risk factors examined in the questionnaire.
DNA barcoding of schistosomes
A total of 25 cox1 barcodes were assembled from S.
haematobium which all matched a previous GenBank
entry EU567128 - Malawian S. haematobium Group I
DNA barcode even though the cox1 was amplified from
two atypical eggs. Owing to much less FTA card mater-
ial, in total 5 cox1 barcodes were assembled from S.
mansoni retrieved from Namila village. These sequences
matched two previously known cox1 barcodes JQ289610 –
S. mansoni Group IV (Coastal Kenya and Zambia) and
JQ289739 – S. mansoni Group V (Zambia) and is the first
time Malawian S. mansoni has been characterized at the
molecular level.
Malacological surveys
16 freshwater sites were inspected for the presence of
aquatic snails, these habitats ranged from natural wet
marshy areas adjacent to the Shire River to large ponds
that represent permanent standing water bodies e.g. the
ox-bow lake at Mpangeni, as well as artificial habitats
such as irrigation scheme canals (Figure 1). Across thesehabitats water chemistry values ranged broadly: pH 8.4-
9.5, conductivity 274-1505 μS and temperature 28.5-
33.6°C. A total of 7 species of mollusc were encountered
with certain species more broadly distributed across the
habitats than others; 2 locations were devoid of snails.
Following morphological identification keys, the species
list with number of times encountered (n sites encoun-
tered) is as follows: Bellamya sp. (5), Bulinus globosus
(7), Bulinus forskali (7), Physa sp. (2), Lanistes sp. (7),
Lymnaea natalensis (2) and Melanoides sp. (8). No
population of Biomphalaria was found nor remnant
shells thereof. Whilst over 250 B. globosus were collected
across the 7 habitats encountered, none was observed to
shed fork-tailed cercariae. This snail species was most
abundant at the ox-bow lake of Mpangeni.
Discussion
Our survey has added to the growing body of evidence
that PSAC can have overt schistosomiasis and has re-
vealed the occurrence of both urogential and intestinal
schistosomiasis in Chikhwawa. The occurrence and se-
verity of schistosomiasis in PSAC is currently receiving
considerable attention for two reasons. First, it is in-
creasingly recognized that the extent and significance of
disease in this age group has been largely overlooked
Figure 6 PSAC frequently accompany their mothers into the
water when washing upon concrete slabs as shown here at
Mpangeni [Inset: an atypical egg (left) alongside a typical egg
(right) of S. haematobium. The egg on the left is approximately
190 μm in length and resembles Schistosoma leiperi, a schistosome
commonly found in wild antelopes].
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eric WHO de-worming guidelines that include PSAC, this
will inevitably lead to a considerable underestimation of
the PZQ needed within the NCP [24]. PZQ is presently
donated free to WHO then is later distributed to each
NCP for preventive chemotherapy in SAC alone [13,14].
Furthermore, off-label use is not formally encouraged by
the donor, MercK-KGa, owing to ambiguities in original
licensing of PZQ (Biltricide®). To counter this, an initiative
to develop an appropriate pediatric formulation with re-
vised pharmaceutical licensing and labelling is ongoing
[13]. Second, improved estimates of the burden of disease
and need for treatment of PSAC within NCPs, and better
understanding of the challenges of programme delivery in
the group is urgently needed. Our findings also highlight
the need to evaluate schistosomiasis in PSAC in other
parts of Malawi where urogenital schistosomiasis is con-
sidered hyper-endemic and significant morbidity in other
groups has been reported [42], for example, a recent sur-
vey in Zomba near Lake Chilwa reported an egg-patent
prevalence of S. haematobium in 20% of the PSAC sur-
veyed [43]. Identification and treatment of these children
is needed, ideally with an appropriate pediatric PZQ for-
mulation, but until then, crushed or divided tablets can be
used [15,19,44-46].
The extent of schistosomiasis
Accurately estimating the prevalence of schistosomiasis in
PSAC is not easy especially when infections are only re-
cently acquired and therefore egg burdens may not have
reached diagnostic thresholds of all detection methods
[14]. Similarly, host antibody responses, although very
sensitive, can have a 2-3 month temporal lag behind schis-
tosome antigen detection methods [25]. Nonetheless, the
extent of schistosomiasis in PSAC was considerable, with
slightly more than half (53.9%) having evidence of infec-
tion and although the relationship of serology and active
infection can be confounded by history of treatment. In
the context of PSAC, where there has been no previous
treatment, then SEA-ELISA in this instance could be con-
sidered the ‘gold standard’. Increasing age was significantly
associated with increased prevalence and intensity of anti-
body responses and egg-patent infections, in keeping with
results from studies elsewhere [16]. This occurs both be-
cause the cumulative level and daily duration of exposure
in environmental water bodies increases as the child
grows older and because schistosome worm populations
in infected children mature to full egg laying fecundity,
thereby increasing SEA levels. The high levels of cumu-
lative water contact in habitats where suitable snails
were found in this study suggest continuous local risk of
transmission in this age group and is similar to those
previously demonstrated in PSAC on the shoreline of
Lake Albert [47].The situation in mothers is perhaps even more alarm-
ing as 94.5% of mothers were positive for schistosomiasis
by SEA-ELISA with slightly under half (45.1%) having
active infection upon the basis of egg excretion or CCA-
dipstick results [22]. It is well-known that parasitological
methods are insensitive for intestinal schistosomiasis
which has led to the creation of a pocket-prevalence-chart
to correct upwardly observed egg-based prevalence values
[48] and using this chart would infer a ‘true’ prevalence of
50-60% for intestinal schistosomiasis alone. Taken as a
whole with urine-filtration and antigen methods, this loca-
tion should be considered a high-risk environment for
schistosomiasis. However, amongst the mothers, general
awareness of schistosomiasis was very low which likely
contributes to behaviour that continues to sustain high
transmission; more than half of the women daily bathed
or washed clothes in environmental water. This also influ-
enced childhood exposure; PSAC accompanied their
mothers at the waters’ edge, infant bathing was directly
witnessed during snail surveys and 1 in 5 PSAC were re-
ported to be bathed daily in this water (Figure 6). Similar
practices have been reported elsewhere [16].
Persistent infection with schistosomiasis typically gives
rise to chronic multi-organ damage through immunopath-
ological lesions to trapped eggs [1]. Even light egg-patent
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are considered detrimental to well-being, especially in
younger children who are at a more vulnerable stage in
growth and development [49,50]. By contrast, microhae-
maturia and albuminuria are very clear indicators of lower
urinary tract disease and the prognosis of such individuals
without access to treatment likely to be poor, with clear
detrimental clinical outcomes downstream [51]. As shown
in Table 1 and Figure 6, elevated levels of albuminuria
were strongly associated with S. haematobium infection in
both mothers and PSAC [33,52]. We recommend that fu-
ture study of disease sequelae with ultrasonography is a
priority, and would add to other evidence accrued in Mali
and Zimbabwe of severe urinary tract disease [15,52,53].
Observations on transmission
Active cases of egg-patent S. mansoni infections were
found in 21.5% of mothers in the first 6 villages and
overall, 24.9% of mothers and 9.1% of children had evi-
dence of intestinal schistosomiasis by urine CCA-
dipsticks. The occurrence of intestinal schistosomiasis in
this area is intriguing. It has previously been assumed
that this area is only endemic for urogenital schistosom-
iasis [42,54,55]. Whilst snail surveys confirmed the local
presence of B. globosus, no population of Biomphalaria
was found so the current transmission risk of S. mansoni
could be considered low. DNA barcoding showed that
the S. mansoni found in Chikhwawa has an identical
DNA barcode to other inspected isolates from more
northern parts of Malawi together with other isolates
from this region of continental southern Africa, i.e. S.
mansoni Groups IV & V in Zambia [41].
To explain this unusual epidemiology, two potential
hypotheses are feasible which are not mutually exclusive.
First, that infections of intestinal schistosomiasis were
not locally acquired and were contracted elsewhere, e.g.
around Blantyre, which might explain why mothers were
at greater risk owing to longer peripatetic history than
their child. Second, that local transmission of intestinal
schistosomiasis occurs but intermittently through time,
e.g. shortly after periods of prior flooding. Populations of
Biomphalaria are typically restricted to parts of Africa
where thermal maxima are not as extreme [2] but could
potentially colonize Chikhwawa when washed-in during
local flooding. Nevertheless the prevalence of schisto-
somiasis reported here is much higher than that re-
ported previously by Bowie et al. [54] in surveys of SAC
using standard parasitological sampling.
As B. globosus is an intermediate snail host of S. hae-
matobium in Malawi [43,46,56,57], it was unsurprising
that local prevalence of urogenital schistosomiasis was
high close to locations where these were found, see
Figure 1. DNA barcoding revealed the presence of one
of the two groups of S. haematobium, i.e. Group I, inthe sample and an inferred absence of Group II types
[40]. Group I types are widespread across Africa whereas
Group II is restricted to coastal East African and associ-
ated islands in the Indian Ocean. Although atypical eggs
were found which might be considered to be Schisto-
soma leiperi, see Figure 6, DNA barcoding suggested
that these were of S. haematobium origin with typical
mitochondrial sequences, which suggesting that these
putative hybrids have retained a maternal mitochondrial
lineage from an ancestral S. haematobium parental stock
[40]. Nonetheless, with the occurrence of atypical eggs,
zoonotic transmission should be considered further.
Conclusion
We have demonstrated a significant but previously over-
looked burden of urogenital schistosomiasis amongst
PSAC and their mothers in Chikhwawa district, and oc-
currence of co-infection with intestinal schistosomiasis.
To conclude, greater surveillance of schistosomiasis in
PSAC and their mothers throughout Malawi is advised
alongside much needed interventions administering
PZQ to them. Further investigation of the extent of pu-
tative zoonotic transmission of urogenital schistosomia-
sis and local transmission of intestinal schistosomiasis in
this southern part of Malawi is recommended.
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